Research Analysts’ Price Target Changes for August 6th (BAM, CHYM, DT, ELAN, ELF, EPAM, EPC, ESTA, FOUR, GENI)

Research Analysts’ price target changes for Thursday, August 6th:

Brookfield Asset Management (NYSE:BAM) (TSE:BAM.A) had its price target increased by UBS Group AG from $48.00 to $55.00. UBS Group AG currently has a neutral rating on the stock.

Chime Financial (NASDAQ:CHYM) had its price target increased by UBS Group AG from $26.00 to $28.00. UBS Group AG currently has a neutral rating on the stock.

Dynatrace (NYSE:DT) had its price target raised by UBS Group AG from $60.00 to $65.00. The firm currently has a buy rating on the stock.

Elanco Animal Health (NYSE:ELAN) had its price target raised by UBS Group AG from $31.00 to $33.00. UBS Group AG currently has a buy rating on the stock.

e.l.f. Beauty (NYSE:ELF) had its price target boosted by UBS Group AG from $80.00 to $89.00. They currently have a neutral rating on the stock.

EPAM Systems (NYSE:EPAM) had its price target lowered by Needham & Company LLC from $135.00 to $120.00. Needham & Company LLC currently has a buy rating on the stock.

Edgewell Personal Care (NYSE:EPC) had its target price increased by UBS Group AG from $29.00 to $32.00. They currently have a neutral rating on the stock.

Establishment Labs (NASDAQ:ESTA) had its price target raised by Needham & Company LLC from $86.00 to $95.00. Needham & Company LLC currently has a buy rating on the stock.

Establishment Labs (NASDAQ:ESTA) had its target price boosted by BTIG Research from $96.00 to $103.00. The firm currently has a buy rating on the stock.

Shift4 Payments (NYSE:FOUR) had its price target lowered by BTIG Research from $70.00 to $60.00. They currently have a buy rating on the stock.

Genius Sports (NYSE:GENI) had its target price boosted by BTIG Research from $9.00 to $10.00. BTIG Research currently has a buy rating on the stock.

Geo Group (NYSE:GEO) had its target price raised by JonesTrading from $33.00 to $40.00. They currently have a buy rating on the stock.

GlobalFoundries (NASDAQ:GFS) had its price target lowered by TD Cowen from $85.00 to $75.00. They currently have a buy rating on the stock.

Graphic Packaging (NYSE:GPK) had its price target raised by UBS Group AG from $11.00 to $12.00. They currently have a neutral rating on the stock.

Global Payments (NYSE:GPN) had its price target raised by UBS Group AG from $80.00 to $91.00. They currently have a neutral rating on the stock.

Warrior Met Coal (NYSE:HCC) had its price target cut by UBS Group AG from $100.00 to $98.00. They currently have a buy rating on the stock.

HubSpot (NYSE:HUBS) had its price target trimmed by TD Cowen from $250.00 to $220.00. The firm currently has a hold rating on the stock.

International Flavors & Fragrances (NYSE:IFF) had its price target boosted by UBS Group AG from $84.00 to $91.00. They currently have a neutral rating on the stock.

Mirum Pharmaceuticals (NASDAQ:MIRM) had its price target lowered by TD Cowen from $145.00 to $140.00. They currently have a buy rating on the stock.

MACOM Technology Solutions (NASDAQ:MTSI) had its target price raised by Needham & Company LLC from $400.00 to $410.00. The firm currently has a buy rating on the stock.

BeOne Medicines (NASDAQ:ONC) had its price target raised by TD Cowen from $424.00 to $454.00. The firm currently has a buy rating on the stock.

Paycom Software (NYSE:PAYC) had its price target raised by UBS Group AG from $195.00 to $205.00. UBS Group AG currently has a buy rating on the stock.

Paycom Software (NYSE:PAYC) had its price target increased by TD Cowen from $149.00 to $244.00. The firm currently has a buy rating on the stock.

Insulet (NASDAQ:PODD) had its price target cut by UBS Group AG from $174.00 to $150.00. The firm currently has a neutral rating on the stock.

Insulet (NASDAQ:PODD) had its price target cut by TD Cowen from $294.00 to $144.00. They currently have a hold rating on the stock.

Protagonist Therapeutics (NASDAQ:PTGX) had its target price raised by Citigroup Inc. from $130.00 to $175.00. Citigroup Inc. currently has a buy rating on the stock.

RxSight (NASDAQ:RXST) had its target price boosted by UBS Group AG from $5.50 to $6.30. UBS Group AG currently has a neutral rating on the stock.

Sight Sciences (NASDAQ:SGHT) had its price target increased by UBS Group AG from $7.00 to $8.00. The firm currently has a buy rating on the stock.

NuScale Power (NYSE:SMR) had its price target cut by Citigroup Inc. from $7.50 to $6.50. The firm currently has a sell rating on the stock.

Valvoline (NYSE:VVV) had its price target lowered by TD Cowen from $47.00 to $45.00. The firm currently has a buy rating on the stock.

Block (NYSE:XYZ) had its price target boosted by TD Cowen from $101.00 to $105.00. TD Cowen currently has a buy rating on the stock.